Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors

Journal of the American College of Surgeons

Volumn 198, Issue 5, 2004, Pages 722-731

  Cleary, Sean P ^a   Gryfe, Robert ^a   Guindi, Maha ^b   Greig, Paul ^b   Smith, Lloyd ^c   MacKenzie, Robert ^d,e   Strasberg, Steven ^f   Hanna, Sherif ^g   Taylor, Bryce ^b   Langer, Bernard ^b   Gallinger, Steven ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d TORONTO EAST GENERAL HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f WASHINGTON UNIVERSITY   (United States)

^g SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL; HUMAN; HUMAN TISSUE; JAUNDICE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

EID: 11144357998     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.01.008     Document Type: Article

References (34)

1. Wu X.C., Hotes J.L., Fulton P.J., et al. Cancer in North America - 1999. 1995;2002 North American Association of Central Cancer Registries, Springfield, IL
2. Greenlee R.T., Murray T., Bolden S., et al. Cancer statistics 2000. CA Cancer J Clin. 50:2000;7-33
3. nded. 2000;1749-1783 Churchill-Livingston, Philadelphia
4. Nitecki S.S., Sarr M.G., Colby T.V., van Heerden J.A. Long term survival after resection of ductal adenocarcinoma of the pancreas is it really improving? Ann Surg. 221:1995;59-66
5. Wade T.P., El-Gazzawy A.G., Virgo K.S., Johnson F.E. The Whipple resection for cancer in U.S. Department of Veterans Affairs hospitals. Ann Surg. 221:1995;241-248
6. Harris G.J., Gaskill H.V., Cruz A.B. Carcinoma of the pancreas a retrospective review. J Surg Oncol. 45:1990;184-189
7. Crile G. Jr. The advantages of bypass over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 130:1970;1049-1053
8. Shapiro T.M. Adenocarcinoma of the pancreas. A statistical analysis of bypass vs Whipple resection in good risk patients. Ann Surg. 182:1975;715-721
9. Crist D.W., Sitzmann J.V., Cameron J.L. Improved hospital mortality after Whipple operation. Ann Surg. 206:1987;358-373
10. Edge S.B., Schmieg R.E., Rosenlof L.K., Wilhelm M.C. Pancreas cancer resection outcome in American university centres 1989-1990. Cancer. 71:1993;3502-3508
11. Yeo C.J., Cameron J.L., Sohn T.A., et al. Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg. 226:1997;248-260
12. Trede M., Schwall G., Saeger H.D. Survival after pancreaticoduodenectomy 118 consecutive resections without an operative mortality. Ann Surg. 211:1990;447-458
13. Simunovic M., To T., Theriault M., Langer B. Relation between hospital surgical volume and outcome for pancreatic resection for neoplasm in a publicly funded health care system. CMAJ. 160:1999;643-648
14. Greer R.J., Brennan M.F. Resection of pancreatic adenocarcinoma prognostic indicators for survival. Am J Surg. 165:1993;68-73
15. Cameron J.L., Crist D.W., Sitzman J.V., et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 161:1991;120-125
16. Sperti C., Pasquali C., Piccoli A., Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 83:1996;625-631
17. Edge S.B., Schmeig R.E., Rosenlof L.K., Wilhelm M.C. Pancreas cancer resection outcome in American university centers in 1989-1990. Cancer. 71:1993;3502-3507
18. Yeo C.J., Sohn T.A., Cameron J.L., et al. Periampullary adenocarcinoma analysis of 5-year survivors. Ann Surg. 227:1998;821-831
19. Conlon K.C., Klimstra D.S., Brennan M.F. Long term survival after curative resection for pancreatic ductal adenocarcinoma clinicopathological analysis of 5-year survivors. Ann Surg. 223:1996;273-279
20. Sohn T.A., Yeo C.J., Cameron J.L., et al. Resected adenocarcinoma of the pancreas - 616 patients results, outcomes, and prognostic indicators. J Gastrointest Surg. 4:2000;567-579
21. rd series. 1997;64 Armed Forces Institute of Pathology, Washington, DC
22. th ed. 2002;JB Lippincott, Philadelphia
23. Kaplan E., Meier P. Non-parametric estimation from incomplete observations. J Am Stat. 53:1958;457-481
24. Cox D.R. Regression models and life tables. J Royal Stat Soc. 34:1972;178-220
25. Burris H.A., Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer a randomized trial. J Clin Oncol. 15:1997;2403-2413
26. Baumel H., Huguier M., Mandershied J.C., et al. Results of resection for cancer of the exocrine pancreas a study from the French Association of Surgery. Br J Surg. 81:1994;102-107
27. Trede M., Saeger H.D., Schwall G., Rumstadt B. Resection of pancreatic cancer - surgical achievements. Lang Arch Surg. 383:1998;121-128
28. Gujonsson B. Survival statistics gone awry pancreatic cancer, a case in point. J Clin Gastroenterol. 35:2002;180-184
29. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas 201 patients. Ann Surg. 221:1995;721-731
30. Magistrelli P., Antinori A., Crucitti A., et al. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol. 74:2000;36-40
31. Ahmad N., Lewis J., Ginsberg G., et al. Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol. 96:2001;2609-2615
32. Lal G., Liu G., Schmocker B., et al. Inherited predisposition to pancreatic adenocarcinoma role of family history and germline p16, BRCA1 and BRCA2 mutations. Cancer Res. 60:2000;409-416
33. Hahn S.A., Greenhalf B., Ellis I., et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 95:2003;214-221
34. Yeo C.J., Cameron J.L., Lillemoe K.D., et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2 randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg. 236:2002;355-366